Alison L Van Dyke1, Meredith S Shiels1, Gieira S Jones1, Ruth M Pfeiffer2, Jessica L Petrick3, Jennifer L Beebe-Dimmer4,5, Jill Koshiol1. 1. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. 2. Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. 3. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. 4. Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. 5. Population Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Abstract
BACKGROUND: Biliary tract cancers (BTCs) are rare but deadly cancers (gallbladder cancer [GBC], intrahepatic cholangiocarcinoma [ICC], extrahepatic cholangiocarcinoma [ECC], and ampulla of Vater cancer [AVC]). A recent US study reported increasing GBC incidence among people younger than 45 years and blacks; however, it did not examine trends for other biliary tract sites. METHODS: This study characterized demographic differences in BTC incidence rates and time trends by anatomic site. Population-based North American Association of Central Cancer Registries data were used to calculate age-adjusted incidence rates, incidence rate ratios (IRRs), and estimated annual percent changes (eAPCs) for 1999-2013 by site and demographic group. For sites with significant differences in eAPC by age group, IRRs were compared by age group. RESULTS: GBC incidence rates declined among women (eAPC, -0.5%/y; P = .01) and all racial/ethnic groups except for non-Hispanic blacks, among whom rates increased (1.8%/y; P < .0001). Although GBC rates increased among 18- to 44-year-olds (eAPC, 1.8%/y; P = .01), they decreased among people 45 years old or older (-0.4%/y; P = .009). Sex (P < .0001) and racial/ethnic differences (P = .003 to .02) in GBC incidence were larger for younger people than older people. During this period, ICC (eAPC, 3.2%/y; P < .0001) and ECC rates (1.8%/y; P = .001) steadily increased across sex and racial/ethnic groups. Although AVC incidence rates increased among younger adults (eAPC, 1.8%/y; P = .03) but not older adults (-0.20%/y; P = .30), sex and racial/ethnic IRRs did not differ by age. CONCLUSIONS: Differential patterns of BTC rates and temporal trends have been identified by anatomic site and demographic groups. These findings highlight the need for large pooling projects to evaluate BTC risk factors by anatomic site.
BACKGROUND:Biliary tract cancers (BTCs) are rare but deadly cancers (gallbladder cancer [GBC], intrahepatic cholangiocarcinoma [ICC], extrahepatic cholangiocarcinoma [ECC], and ampulla of Vater cancer [AVC]). A recent US study reported increasing GBC incidence among people younger than 45 years and blacks; however, it did not examine trends for other biliary tract sites. METHODS: This study characterized demographic differences in BTC incidence rates and time trends by anatomic site. Population-based North American Association of Central Cancer Registries data were used to calculate age-adjusted incidence rates, incidence rate ratios (IRRs), and estimated annual percent changes (eAPCs) for 1999-2013 by site and demographic group. For sites with significant differences in eAPC by age group, IRRs were compared by age group. RESULTS: GBC incidence rates declined among women (eAPC, -0.5%/y; P = .01) and all racial/ethnic groups except for non-Hispanic blacks, among whom rates increased (1.8%/y; P < .0001). Although GBC rates increased among 18- to 44-year-olds (eAPC, 1.8%/y; P = .01), they decreased among people 45 years old or older (-0.4%/y; P = .009). Sex (P < .0001) and racial/ethnic differences (P = .003 to .02) in GBC incidence were larger for younger people than older people. During this period, ICC (eAPC, 3.2%/y; P < .0001) and ECC rates (1.8%/y; P = .001) steadily increased across sex and racial/ethnic groups. Although AVC incidence rates increased among younger adults (eAPC, 1.8%/y; P = .03) but not older adults (-0.20%/y; P = .30), sex and racial/ethnic IRRs did not differ by age. CONCLUSIONS: Differential patterns of BTC rates and temporal trends have been identified by anatomic site and demographic groups. These findings highlight the need for large pooling projects to evaluate BTC risk factors by anatomic site.
Authors: Leticia Nogueira; Neal D Freedman; Eric A Engels; Joan L Warren; Felipe Castro; Jill Koshiol Journal: Am J Epidemiol Date: 2014-01-26 Impact factor: 4.897
Authors: Yuhree Kim; Aslam Ejaz; Amit Tayal; Gaya Spolverato; John F P Bridges; Robert A Anders; Timothy M Pawlik Journal: Cancer Date: 2014-06-10 Impact factor: 6.860
Authors: Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn Journal: Clin Gastroenterol Hepatol Date: 2007-08-06 Impact factor: 11.382
Authors: Rubayat Rahman; Eduardo J Simoes; Chester Schmaltz; Christian S Jackson; Jamal A Ibdah Journal: Cancer Med Date: 2017-03-20 Impact factor: 4.452
Authors: Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn Journal: PLoS One Date: 2017-10-19 Impact factor: 3.240
Authors: Jill Koshiol; Vanessa Van De Wyngard; Emma E McGee; Paz Cook; Ruth M Pfeiffer; Noldy Mardones; Karie Medina; Vanessa Olivo; Karen Pettit; Sarah S Jackson; Fabio Paredes; Raúl Sanchez; Andrea Huidobro; Miguel Villaseca; Enrique Bellolio; Hector Losada; Juan Carlos Roa; Allan Hildesheim; Juan Carlos Araya; Catterina Ferreccio Journal: Am J Epidemiol Date: 2021-02-01 Impact factor: 4.897
Authors: Safak Gül-Klein; Paulina Schmitz; Wenzel Schöning; Robert Öllinger; Georg Lurje; Sven Jonas; Deniz Uluk; Uwe Pelzer; Frank Tacke; Moritz Schmelzle; Johann Pratschke; Ramin Raul Ossami Saidy; Dennis Eurich Journal: Cancers (Basel) Date: 2022-06-11 Impact factor: 6.575
Authors: Sandra J Casak; Shan Pradhan; Lola A Fashoyin-Aje; Yi Ren; Yuan-Li Shen; Yuan Xu; Edwin Chiu Yuen Chow; Ye Xiong; Jeanne Fourie Zirklelbach; Jiang Liu; Rosane Charlab; William F Pierce; Nataliya Fesenko; Julia A Beaver; Richard Pazdur; Paul G Kluetz; Steven J Lemery Journal: Clin Cancer Res Date: 2022-07-01 Impact factor: 13.801
Authors: T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica Journal: Curr Probl Surg Date: 2020-06-30 Impact factor: 1.909
Authors: Chirag Nepal; Bin Zhu; Colm J O'Rourke; Deepak Kumar Bhatt; Donghyuk Lee; Lei Song; Difei Wang; Alison L Van Dyke; Hyoyoung Choo-Wosoba; Zhiwei Liu; Allan Hildesheim; Alisa M Goldstein; Michael Dean; Juan LaFuente-Barquero; Scott Lawrence; Karun Mutreja; Mary E Olanich; Justo Lorenzo Bermejo; Catterina Ferreccio; Juan Carlos Roa; Asif Rashid; Ann W Hsing; Yu-Tang Gao; Stephen J Chanock; Juan Carlos Araya; Jesper B Andersen; Jill Koshiol Journal: J Hepatol Date: 2020-12-01 Impact factor: 25.083
Authors: Jessica L Petrick; Andrea A Florio; Xuehong Zhang; Anne Zeleniuch-Jacquotte; Jean Wactawski-Wende; Stephen K Van Den Eeden; Frank Z Stanczyk; Tracey G Simon; Rashmi Sinha; Howard D Sesso; Catherine Schairer; Lynn Rosenberg; Thomas E Rohan; Mark P Purdue; Julie R Palmer; Martha S Linet; Linda M Liao; I-Min Lee; Jill Koshiol; Cari M Kitahara; Victoria A Kirsh; Jonathan N Hofmann; Chantal Guillemette; Barry I Graubard; Edward Giovannucci; J Michael Gaziano; Susan M Gapster; Neal D Freedman; Lawrence S Engel; Dawn Q Chong; Yu Chen; Andrew T Chan; Patrick Caron; Julie E Buring; Gary Bradwin; Laura E Beane Freeman; Peter T Campbell; Katherine A McGlynn Journal: Hepatology Date: 2020-08 Impact factor: 17.298
Authors: Mansi Arora; James M Bogenberger; Amro Abdelrahman; Jennifer L Leiting; Xianfeng Chen; Jan B Egan; Aradhana Kasimsetty; Elzbieta Lenkiewicz; Smriti Malasi; Pedro Luiz Serrano Uson; Bolni Marius Nagalo; Yumei Zhou; Marcela A Salomao; Heidi E Kosiorek; Esteban Braggio; Michael T Barrett; Mark J Truty; Mitesh J Borad Journal: Cancer Chemother Pharmacol Date: 2020-05-21 Impact factor: 3.288
Authors: Taylor D Ellington; Behnoosh Momin; Reda J Wilson; S Jane Henley; Manxia Wu; A Blythe Ryerson Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-07-08 Impact factor: 4.090